Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea

Last updated: November 25, 2021
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Amenorrhea

Treatment

N/A

Clinical Study ID

NCT05150301
8425
  • Ages > 32
  • All Genders

Study Summary

An "outborn" birth is a premature birth that occurs in an unsuitable level center at the end of the child (unlike "inborn" births).

This study aims to describe the morbidity and mortality of very premature newborns (gestational age less than 32 weeks of amenorrhea) born outside a maternity hospital of appropriate level between January 1, 2016 and December 31, 2020, and assessment of the preventable or non-preventable nature of these so-called "outborn" births.

The aim of this research is to write down the short-term mortality and morbidity of newborns born at a gestational age <32 weeks of amenorrhea outside a level III maternity hospital in Alsace between January 1, 2016 and December 31, 2020.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Newborn under 32 weeks of amenorrhea at the time of birth, born in Alsace in one of thelevel I, IIa, or IIb maternity hospitals, between January 1, 2016 and December 31, 2020

Exclusion

Exclusion criteria:

  • Fetal death in utero

Study Design

Total Participants: 134
Study Start date:
November 01, 2021
Estimated Completion Date:
October 30, 2022

Connect with a study center

  • Service de Réanimation Néonatale - Hôpitaux Universitaires de Strasbourg

    Strasbourg, 67091
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.